RxDoctor Payments Data

Brianna Banerjee, PA

Physician Assistant · Holly Springs, NCNPI 1639867906

Payments from drug & device makers

$1,193in general payments, 2019–2025

Across 43 payments — averaging $27.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$320
  • Braeburn Inc.$303
  • Amgen$121
  • Scilex Pharmaceuticals Inc.$99
  • Astellas Pharma US Inc$96
  • Forte Bio-pharma LLC$71
  • plus $183 from 3 others

What the payments were for

  • Food & beverage$1,193100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,193 in reported general payments places this provider in the 70th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$67,395
Medicare patients
137
Services billed
591

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Xtampza ErOxycodone Myristate179$111,323
OxycontinOxycodone Hcl74$59,772
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen385$58,896
LinzessLinaclotide55$34,077
BelbucaBuprenorphine Hcl35$23,045
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl83$19,009
Diazepam18$18,454
NucyntaTapentadol Hcl17$15,251
Oxycodone Hcl690$13,994
MovantikNaloxegol Oxalate29$11,931
Fentanyl60$10,755
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen266$10,628
ZtlidoLidocaine15$10,255
Buprenorphine39$9,074
ZubsolvBuprenorphine Hcl/Naloxone Hcl11$8,937

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta$320$149,618231 claims
AbbVieLinzess$60$34,07755 claims
Scilex Pharmaceuticals Inc.Ztlido$99$10,25515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Holly Springs

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →